Nirvana Life Sciences Inc (NIRV.X) Stock Statistics & Valuation Metrics
Total Valuation
Nirvana Life Sciences Inc has a market cap or net worth of CAD 1.14M. The enterprise value is CAD 440.68B.
- Market Cap
- CAD 1.14M
- Enterprise Value
- CAD 440.68B
Share Statistics
Nirvana Life Sciences Inc has 22,823,301 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,823,301
- Owned by Insiders
- 12.87%
- Owned by Institutions
- ―
Financial Efficiency
Nirvana Life Sciences Inc’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 24.46%.
- Return on Equity (ROE)
- 0.25
- Return on Assets (ROA)
- -18.81
- Return on Invested Capital (ROIC)
- 24.46%
- Return on Capital Employed (ROCE)
- 0.23
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- ―
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Nirvana Life Sciences Inc is -5.60. Nirvana Life Sciences Inc’s PEG ratio is 1.70.
- PE Ratio
- -5.60
- PS Ratio
- 0.00
- PB Ratio
- -3.06
- Price to FCF
- -0.34
- Price to Operating Cash Flow
- -1.61
- PEG Ratio
- 1.70
Income Statement
In the last 12 months, Nirvana Life Sciences Inc had revenue of 0 and earned -365.92K in profits. Earnings per share was -0.08.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -339.94K
- Pretax Income
- -365.92K
- Net Income
- -365.92K
- EBITDA
- -321.63K
- Earnings Per Share (EPS)
- -0.08
Cash Flow
In the last 12 months, operating cash flow was -994.85K and capital expenditures 0, giving a free cash flow of -994.85K billion.
- Operating Cash Flow
- -994.85K
- Free Cash Flow
- -994.85K
- Free Cash Flow per Share
- -0.04
Dividends & Yields
Nirvana Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -294.66%
- Earnings Yield
- -17.85%
Stock Price Statistics
- Beta
- -3.25
- 52-Week Price Change
- -28.57%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 70.04
- Average Volume (3m)
- 4,113
Important Dates
Nirvana Life Sciences Inc upcoming earnings date is Jan 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 24, 2026
- Next Earnings Date
- Jan 05, 2027
- Ex-Dividend Date
- ―
Financial Position
Nirvana Life Sciences Inc as a current ratio of 0.01, with Debt / Equity ratio of -6.64%
- Current Ratio
- 0.01
- Quick Ratio
- 0.01
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- -0.30
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Nirvana Life Sciences Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Nirvana Life Sciences Inc EV to EBITDA ratio is -1.78, with an EV/FCF ratio of -0.44.
- EV to Sales
- 0.00
- EV to EBITDA
- -1.78
- EV to Free Cash Flow
- -0.44
- EV to Operating Cash Flow
- -0.44
Balance Sheet
Nirvana Life Sciences Inc has CAD 1,744.00 in cash and marketable securities with CAD 104.79K in debt, giving a net cash position of -CAD 103.05K billion.
- Cash & Marketable Securities
- CAD 1,744.00
- Total Debt
- CAD 104.79K
- Net Cash
- -CAD 103.05K
- Net Cash Per Share
- CAD 0.00
- Tangible Book Value Per Share
- -CAD 0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Nirvana Life Sciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
